The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study.
 
Jinyong Kim
No Relationships to Disclose
 
Kyung-Hun Lee
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
 
Yeon Hee Park
Honoraria - AstraZeneca; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boryung; Daiichi-Sankyo; Eisai; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Gencurix (Inst); Genome Insight (Inst); NGeneBio (Inst); Pfizer; Roche (Inst)
 
Ching-Hung Lin
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer
 
Yen-Shen Lu
Honoraria - AstraZeneca; Daiichi Sankyo/UCB Japan; Eisai; EuroPharma; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Takayuki Ueno
Honoraria - AstraZeneca Japan; Chugai Pharma; Eisai; Novartis
Research Funding - Lilly Japan (Inst)
 
Yoon Sim Yap
Honoraria - AstraZeneca; Eisai; Lilly; MSD; Novartis; Pfizer; Specialised Therapeutics
Consulting or Advisory Role - AstraZeneca; Eisai; Inivata; Lilly; MSD; Novartis; Pfizer
Research Funding - MSD Oncology (Inst)
 
Winnie Yeo
No Relationships to Disclose
 
Qiang Liu
Consulting or Advisory Role - AstraZeneca; Novartis
Speakers' Bureau - AstraZeneca; Eisai; Novartis; Pfizer; Roche
Research Funding - Eisai
 
Roland Ching-Yu Leung
No Relationships to Disclose
 
Yoichi Naito
No Relationships to Disclose
 
Huiping Li
No Relationships to Disclose
 
Han-Byoel Lee
Leadership - DCGen
Stock and Other Ownership Interests - DCGen
Honoraria - Alvogen Korea; Boryung; Roche; Takeda
Consulting or Advisory Role - Boryung; Lilly; Novartis
Research Funding - Devicor Medical Products
Patents, Royalties, Other Intellectual Property - Patent for an NGS-based breast cancer multigene prognostic panel
Travel, Accommodations, Expenses - DCGen
 
Wonshik Han
Leadership - DCGen
Stock and Other Ownership Interests - DCGen
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Boryung Pharmaceuticals (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche